Wright Medical Group NV  

(Public, NASDAQ:TRNX)   Watch this stock  
Find more results for TRNX
0.00 (0.00%)
Oct 1 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap 2.48B
P/E     -
Div/yield     -
EPS -0.68
Shares 102.66M
Beta     -
Inst. own 42%

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin -33.50% -57.37%
Operating margin -24.54% -45.72%
EBITD margin - -34.55%
Return on average assets -9.27% -16.09%
Return on average equity -26.64% -35.74%
Employees 2,295 -
CDP Score - -


Prins Bernhardplein 200
+31-20-6754002 (Phone)
+31-10-4718888 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Wright Medical Group NV, formerly Tornier N.V., is a manufacturer of medical devices and focuses on extremities and biologics products. The Company operates through the orthopedic products segment, which includes the design, manufacture, marketing and sales of extremities, biologics, large joint and other products. The Company offers a product portfolio of over 160 extremities products and approximately 20 biologics products that are designed to provide solutions to its surgeon customers. It offers solutions for upper extremities, lower extremities, biologics, sports medicine and other, and large joints. The Company's upper extremities product category includes joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand. The Company's lower extremities product category includes joint implants and bone fusion and fixation devices, including plates, pins, screws, and nails, for the foot and ankle.

Officers and directors

Robert J. Palmisano President, Chief Executive Officer, Executive Director
Age: 71
Bio & Compensation  - Reuters
Lance A. Berry CPA Chief Financial Officer, Senior Vice President
Age: 43
Bio & Compensation  - Reuters
Peter S. Cooke President - International
Age: 50
Bio & Compensation  - Reuters
Kevin D. Cordell President - Lower Extremities and Biologics
Age: 50
Bio & Compensation  - Reuters
J. Wesley Porter Senior Vice President, Chief Compliance Officer
Age: 46
Bio & Compensation  - Reuters
James A. Lightman Senior Vice President, General Counsel, Secretary
Age: 58
Bio & Compensation  - Reuters
William L. Griffin Jr. Senior Vice President and General Manager – BioMimetic Therapeutics
Age: 67
Bio & Compensation  - Reuters
Julie D. Tracy Senior Vice President and Chief Communications Officer , IR Contact Officer
Age: 52
Bio & Compensation  - Reuters
Robert P. Burrows Senior Vice President - Supply Chain
Age: 69
Bio & Compensation  - Reuters
Gregory Morrison Senior Vice President - Human Resources
Age: 52
Bio & Compensation  - Reuters